Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 9,862 shares at $40.14 ($396K) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Scheduled sale ($396k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.13 | 2,301 | $92K | 23.3% |
| 2 | $40.13 | 2,301 | $92K | 23.3% |
| 3 | $40.14 | 2,630 | $106K | 26.7% |
| 4 | $40.14 | 2,630 | $106K | 26.7% |
| Total | $40.14 avg | 9,862 | $396K | 100% |
| Filing → |
| IONS | SELL | 2026-03-11 | $24.2M | — | Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |